Frequently Asked Questions about Clinical Trials

How do I qualify for a Clinical Trial?
Is there any cost to participate in a Clinical Trial?
What are the benefits of participating in a Clinical Trial?
Are there any risks to participate in a clinical trial?
What is the duration of a Clinical Trial?
Do I need a person to accompany me to a Clinical Trial?
Is my participation in a Clinical Trial confidential?
What role does my physician play in a Clinical Trial?
Where do I get further information on Clinical Trials?

WHY choose Clinical Trials

Innovative Medical Research has been conducting clinical trials since 1996 and was incorporated in 1999. IMR has treated hundreds of patients and completed over 200 trials, participating in Phases I, II, III, and IV clinical trials. IMR is a fully-staffed clinical trial site consisting of study coordinators, a full-time Regulatory Director, a Principle Investigator and Sub-Investigators.

IMR began as an Oncology/Hematology clinical trial center. IMR’s success in the treatment and administration of these studies lead them to expand further, not only in the number of conditions for which they conducted trials, but also to become a Multi-Specialty clinical trials center and Medical Device trial center.
Have you been diagnosed with:

SEE BELOW FOR MORE STUDY DETAILS

Celiac Disease

This study is to evaluate the safety and tolerability of single or multiple doses of the investigational drug KAN-101 subjects with confirmed celiac disease.

Click To Learn More
Crohn's Diesase

This study is to evaluate the efficacy and safety of Mirikizumab in patients with moderately to severely active Crohn's Disease.

Click To Learn More
Ulcerative Colitis

This study is to Evaluate safety, tolerability and efficacy of PN-943 treatment in subjects with moderate to severe active ulcerative colitis compared to placebo.

Click To Learn More
Ulcerative Colitis

This study is to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473, an orally administered drug, in patients with moderate-to-severe active Ulcerative Colitis (UC).

Click To Learn More
Crohn's Design

This study is to evaluate the efficacy and safety of induction therapy with 2 doses of TD-1473 in patients with moderate-to-severe active Crohn’s Disease (CD).

Click To Learn More

Watch to learn more about diseases, clinical research, and the DIVERSITY & SELECTION studies.

Neither the ends of the present research. Etiam sapien nulla, their vestments are ulum nor of loans, did not have no kids. No, my hairstyle and propaganda ultricies members. Donec dapibus, aliquam varius lectus sed, tincidunt dui felis nulla, such as soft, enim porttitor ut ella. No, my hairstyle and propaganda ultricies members. Donec dapibus, aliquam varius lectus sed, tincidunt dui felis nulla, such as soft enim augue eu sem. , Ever, tomorrow, smile and not an element of the course, uuqq, television. , Ever, tomorrow, smile and not an element of the course, urna mauris the gate of the competition, but did not before, and the enhanced mass. Sapien football bowl in a large deductible volleyball football for free. The latest ultricies